Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences & biomedicine (8) 8
oncology (8) 8
science & technology (8) 8
breast cancer (7) 7
female (6) 6
humans (6) 6
adult (4) 4
middle aged (4) 4
patients (4) 4
tumors (4) 4
aged (3) 3
breast neoplasms - drug therapy (3) 3
breast neoplasms - pathology (3) 3
cancer (3) 3
chemotherapy (3) 3
disease-free survival (3) 3
prognosis (3) 3
research (3) 3
analysis (2) 2
antineoplastic agents - therapeutic use (2) 2
breast neoplasms - genetics (2) 2
breast neoplasms - therapy (2) 2
breast neoplasms/drug therapy (2) 2
cancer therapies (2) 2
chemotherapy, adjuvant (2) 2
denmark (2) 2
endocrine therapy (2) 2
epirubicin - administration & dosage (2) 2
erbb-2 protein (2) 2
follow-up studies (2) 2
gene expression (2) 2
neoplasm staging (2) 2
oncology, experimental (2) 2
poly-adp-ribose binding proteins (2) 2
proportional hazards models (2) 2
statistical analysis (2) 2
treatment outcome (2) 2
administration, oral (1) 1
advanced breast cancer (1) 1
age factors (1) 1
animals (1) 1
anthracycline (1) 1
anthracyclines (1) 1
antibodies, monoclonal, humanized/adverse effects (1) 1
antigens, neoplasm - genetics (1) 1
antigens, neoplasm - metabolism (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - metabolism (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols/administration & dosage (1) 1
biomarkers (1) 1
biomarkers, pharmacological (1) 1
biomarkers, tumor - analysis (1) 1
biotechnology (1) 1
breast neoplasms (1) 1
breast neoplasms - diagnosis (1) 1
breast neoplasms - metabolism (1) 1
breast neoplasms - mortality (1) 1
breast neoplasms - psychology (1) 1
cancer epidemiology (1) 1
cancer patients (1) 1
carcinoma (1) 1
carcinoma - mortality (1) 1
carcinoma, ductal, breast - genetics (1) 1
carcinoma, ductal, breast - secondary (1) 1
carcinoma, ductal, breast - therapy (1) 1
care and treatment (1) 1
case-control studies (1) 1
clinical trial (1) 1
complementary therapies - adverse effects (1) 1
complementary therapies - statistics & numerical data (1) 1
complementary therapies - utilization (1) 1
cyclophosphamide - administration & dosage (1) 1
development and progression (1) 1
disease progression (1) 1
dk/atira/pure/researchoutput/pubmedpublicationtype/d016428 (1) 1
dna topoisomerases, type ii - genetics (1) 1
dna topoisomerases, type ii - metabolism (1) 1
dna-binding proteins - genetics (1) 1
dna-binding proteins - metabolism (1) 1
dose-response relationship, drug (1) 1
double-blind method (1) 1
drug administration schedule (1) 1
drug therapy (1) 1
epidemiology (1) 1
epirubicin (1) 1
epirubicin/administration & dosage (1) 1
estrogens (1) 1
ethical aspects (1) 1
etiology (1) 1
formaldehyde (1) 1
gene expression regulation, neoplastic - drug effects (1) 1
gene expression regulation, neoplastic/drug effects (1) 1
gene mutations (1) 1
genes (1) 1
genetic aspects (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
by Martin, Miguel and Holmes, Frankie A and Ejlertsen, Bent and Delaloge, Suzette and Moy, Beverly and Iwata, Hiroji and Chia, Stephen K L and Šeparović, Robert and Gokmen, Erhan and Bashford, Anna and Kim, Sung-Bae and Jakobsen, Erik Hugger and Ciceniene, Audrone and Inoue, Kenichi and Overkamp, Friedrich and Heijns, Joan B and Armstrong, Anne C and Link, John S and Joy, Anil Abraham and Wong, Alvin and Moran, Susan and Yao, Bin and Xu, Feng and Auerbach, Alan and Buyse, Marc and Chan, Arlene and Harvey, Vernon and Tomek, Rudolf and Robert, Nicholas J and Gore, Ira and Smith, John W and Masuda, Norikazu and Di Sean Kendall, S and Harker, William Graydon and Petrakova, Katarina and Guerrero Zotano, Angel and Simon, Amparo Ruiz and Konstantinovic, Zora Neskovic and Iannotti, Nicholas O and Tassone, Pierfrancesco and Rodriguez, Gladys I and Jáñez Martinez, Noelia and Crespo Massieu, Carmen and Smickoska, Snezana and Somali, Isil and Yilmaz, Ugur and Alonso, Mirta Garcia and Rosales, Adolfo Murias and Cold, Soeren and Knoop, Ann Soegaard and Patt, Debra and Hellerstedt, Beth A and Mayer, Ingrid A and Means-Powell, Julie Ann and Senecal, Francis M and De Boer, Richard Hendry and Shen, Zhenzhou and Luczak, Adam Andrzej and Chui, Joanna W.Y and Tsang, Janice Wing-hang and Lang, Istvan and Rai, Yoshiaki and Hozumi, Yasuo and Ten Tije, Albert J and Ohtani, Shoichiro and Higaki, Kenji and Taguchi, Kazunori and Takahashi, Masato and Filipovic, Sladjana and Rao, Vijayarama Phooshkooru and Gupta, Manish and Petrov, Petar and Coudert, Bruno and Vojnovic, Zeljko and Polya, Zsofia and Miyaki, Toshiko and Yamamoto, Naohito and Brincat, Stephen and Lesniewski-Kmak, Krzysztof and Chmielowska, Ewa and Birhiray, Ruemu E and Citron, Marc L and Papish, Steven William and Berry, William R and Langkjer, Sven Tyge and Garcia Sáenz, José Angel and Arance, Ana Maria and Efrat, Noa and Sarosiek, Tomasz and Grzeda, Lukasz and Manalo, Yvonne and Smith, Julie C and Healey, Tabitha and Dingle, Brian and Franco, Sandra and Sorensen, Peter Grundtvig and Khan, Sarah and Fountzilas, George and Aogi, Kenjiro and Shimizu, Satoru and ... and ExteNET Study Group and ExteNET Study Grp
The lancet oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1688 - 1700
Life Sciences & Biomedicine | Oncology | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Induction of PIK3CA alterations during neoadjuvant letrozole may improve outcome in postmenopausal breast cancer patients
by Skriver, Signe Korsgaard and Jensen, Maj-Britt and Eriksen, Jens-Ole and Ahlborn, Lise Barlebo and Knoop, Ann Soegaard and Rossing, Maria and Ejlertsen, Bent and Laenkholm, Anne-Vibeke
Breast cancer research and treatment, ISSN 0167-6806, 11/2020, Volume 184, Issue 1, pp. 123 - 133
Medical research | Care and treatment | Prognosis | Platelet-derived growth factor | Genes | Patient outcomes | Breast cancer | Postmenopausal women | Research | Antineoplastic agents | Antimitotic agents | Cancer patients | Gene mutations | Medicine, Experimental | Genetic aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Synchronous bilateral breast cancer: a nationwide study on histopathology and etiology
by Mejdahl, Mathias Kvist and Wohlfahrt, Jan and Holm, Marianne and Knoop, Ann Soegaard and Tjonneland, Anne and Melbye, Mads and Kroman, Niels and Balslev, Eva
Breast cancer research and treatment, ISSN 0167-6806, 07/2020, Volume 182, Issue 1, pp. 229 - 238
Life Sciences & Biomedicine | Oncology | Science & Technology | Oncology, Experimental | Analysis | Development and progression | Breast cancer | Research | Histochemistry | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Breast cancer mortality in synchronous bilateral breast cancer patients
by Mejdahl, Mathias Kvist and Wohlfahrt, Jan and Holm, Marianne and Balslev, Eva and Knoop, Ann Soegaard and Tjonneland, Anne and Melbye, Mads and Kroman, Niels
British journal of cancer, ISSN 0007-0920, 04/2019, Volume 120, Issue 7, pp. 761 - 767
Life Sciences & Biomedicine | Oncology | Science & Technology | Neoplasms, Multiple Primary - mortality | Prognosis | Humans | Middle Aged | Mortality | Carcinoma - mortality | Unilateral Breast Neoplasms - mortality | Case-Control Studies | Denmark | Adult | Breast Neoplasms - mortality | Female | Aged | Index Medicus | Epidemiology | Breast cancer | Cancer epidemiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial
by Ejlertsen, Bent and Tuxen, Malgorzata K and Jakobsen, Erik Hugger and Jensen, Maj-Britt and Knoop, Ann Soegaard and Højris, Inger and Ewertz, Marianne and Balslev, Eva and Danø, Hella and Vestlev, Peter Michael and Kenholm, Julia and Nielsen, Dorte L and Bechmann, Troels and Andersson, Michael and Cold, Søren and Nielsen, Hanne Melgaard and Maae, Else and Carlsen, Dorte and Mouridsen, Henning T
Journal of clinical oncology, ISSN 0732-183X, 08/2017, Volume 35, Issue 23, pp. 2639 - 2646
Carcinoma, Ductal, Breast - genetics | Cyclophosphamide - administration & dosage | Follow-Up Studies | Humans | Menopause | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Breast Neoplasms - therapy | Poly-ADP-Ribose Binding Proteins | Neoplasm Grading | Mastectomy | Adult | Female | Chemotherapy, Adjuvant | Carcinoma, Ductal, Breast - secondary | Antigens, Neoplasm - genetics | Survival Rate | DNA-Binding Proteins - genetics | Carcinoma, Ductal, Breast - therapy | Disease-Free Survival | Taxoids - administration & dosage | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Intention to Treat Analysis | DNA Topoisomerases, Type II - genetics | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study
by Buhl, Anna Sofie Kappel and Christensen, Troels Dreier and Christensen, Ib Jarle and Nelausen, Knud Mejer and Balslev, Eva and Knoop, Ann Søegaard and Brix, Eva Harder and Svensson, Else and Glavicic, Vesna and Luczak, Adam and Langkjer, Sven Tyge and Linnet, Søren and Jakobsen, Erik Hugger and Bogovic, Jurij and Ejlertsen, Bent and Rasmussen, Annie and Hansen, Anker and Knudsen, Steen and Nielsen, Dorte and Jensen, Peter Buhl
Breast cancer research and treatment, ISSN 0167-6806, 11/2018, Volume 172, Issue 2, pp. 391 - 400
Epirubicin | Advanced breast cancer | Precision medicine | Predictive biomarker | Life Sciences & Biomedicine | Oncology | Science & Technology | Prospective Studies | Humans | Middle Aged | RNA, Messenger - genetics | Biomarkers, Pharmacological | Proportional Hazards Models | Epirubicin - administration & dosage | Breast Neoplasms - drug therapy | Disease Progression | Disease-Free Survival | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Adult | Female | Aged | Retrospective Studies | Gene Expression Regulation, Neoplastic - drug effects | Neoplasm Proteins - genetics | Precision Medicine | Anthracyclines | RNA | Oncology, Experimental | Medical records | Breast cancer | Research | Gene expression | Ethical aspects | Formaldehyde | Analysis | Genetic research | Drug therapy | Cancer | Index Medicus | Clinical Trial
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial
by Skriver, Signe Korsgaard and Jensen, Maj-Britt and Knoop, Ann Soegaard and Ejlertsen, Bent and Laenkholm, Anne-Vibeke
Breast cancer research : BCR, ISSN 1465-5411, 05/2020, Volume 22, Issue 1, pp. 46 - 46
Life Sciences & Biomedicine | Oncology | Science & Technology | Index Medicus | Endocrine therapy | Neoadjuvant | Breast neoplasms | TILs | Letrozole
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Induction ofPIK3CAalterations during neoadjuvant letrozole may improve outcome in postmenopausal breast cancer patients
by Skriver, Signe Korsgaard and Jensen, Maj-Britt and Eriksen, Jens-Ole and Ahlborn, Lise Barlebo and Knoop, Ann Soegaard and Rossing, Maria and Ejlertsen, Bent and Laenkholm, Anne-Vibeke
Breast cancer research and treatment, ISSN 0167-6806, 11/2020, Volume 184, Issue 1, pp. 123 - 133
Life Sciences & Biomedicine | Oncology | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Adjuvant Cyclophosphamide and DocetaxelWith or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial
by Ejlertsen, Bent and Tuxen, Malgorzata K and Jakobsen, Erik Hugger and Jensen, Maj-Britt and Knoop, Ann Soegaard and Hojris, Inger and Ewertz, Marianne and Balslev, Eva and Dano, Hella and Vestlev, Peter Michael and Kenholm, Julia and Nielsen, Dorte L and Bechmann, Troels and Andersson, Michael and Cold, Soren and Nielsen, Hanne Melgaard and Maae, Else and Carlsen, Dorte and Mouridsen, Henning T
Journal of clinical oncology, ISSN 0732-183X, 08/2017, Volume 35, Issue 23, p. 2639
Life Sciences & Biomedicine | Oncology | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Liposomal cisplatin response prediction in heavily pretreated breast cancer patients: A multigene biomarker in a prospective phase 2 study
by Jakobsen, Erik Hugger and Nielsen, Dorte and Danoe, Hella and Linnet, Soeren and Hansen, Joergen and Lassen, Ulrik Niels and Balslev, Eva and Glavicic, Vesna and Bogovic, Jurij and Knudsen, Steen and Ejlertsen, Bent and Knoop, Ann Søegaard and Buhl, Ulla Hald and Madsen, Mogens Winkel and Buhl, Ida Kappel and Hansen, Anker and Jensen, Thomas and Rasmussen, Annie and Jensen, Peter Buhl and Langkjer, Sven Tyge
Journal of clinical oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e13077 - e13077
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Prediction of exemestane benefit in patients with advanced breast cancer based on diagnostic biopsy mRNA analysis
by Christensen, Troels Dreier and Buhl, Anna Sofie Kappel and Christensen, Ib Jarle and Nelausen, Knud Mejer and Balslev, Eva and Knoop, Ann Søegaard and Brix, Eva Harder and Vestlev, Peter Michael and Ejlertsen, Bent and Kumler, Iben and Luczak, Adam and Langkjer, Sven Tyge and Linnet, Soeren and Jakobsen, Erik and Bogovic, Jurij Antonovic and Glavicic, Vesna and Buhl, Ulla Hald and Jensen, Peter Buhl and Knudsen, Steen and Nielsen, Dorte
Journal of clinical oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e12532 - e12532
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text The Prosigna 50-gene profile and responsiveness to adjuvant anthracycline-based chemotherapy in high-risk breast cancer patients
by Jensen, Maj-Britt and Laenkholm, Anne-Vibeke and Balslev, Eva and Buckingham, Wesley and Ferree, Sean and Glavicic, Vesna and Jensen, Jeanette Dupont and Knoop, Ann Soegaard and Mouridsen, Henning T and Nielsen, Dorte and Nielsen, Torsten O and Ejlertsen, Bent
NPJ breast cancer, ISSN 2374-4677, 02/2020, Volume 6, Issue 1, pp. 7 - 7
Life Sciences & Biomedicine | Oncology | Science & Technology | Chemotherapy | Breast cancer | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Status over klinisk anvendte prognostiske og prædiktive faktorer ved allokering til systemisk behandling efter primær cancer mammae
by Knoop, Ann Søegaard and Rasmussen, Birgitte Bruun
Ugeskrift for læger, ISSN 0041-5782, 09/2007, Volume 169, Issue 36, pp. 2997 - 2999
Journal Article
Details down arrow
14. Brystkræftpatienters brug af komplementær og alternativ medicin - Effekt og interaktioner
by Damkier, Anette and Paludan-Müller, Christine and Knoop, Ann Søegaard
Ugeskrift for læger, ISSN 0041-5782, 09/2007, Volume 169, Issue 37, pp. 3111 - 3114
Journal Article
Details down arrow
15. Prognostic and predictive factors for endocrine treatment in breast carcinoma
by Knoop, Ann Søegaard and Rasmussen, Birgitte Bruun
Ugeskrift for læger, 09/2007, Volume 169, Issue 36, p. 2997
DNA Topoisomerases, Type II - metabolism | Predictive Value of Tests | Receptors, Estrogen - metabolism | Prognosis | Age Factors | Biomarkers, Tumor - analysis | Humans | Antineoplastic Agents - therapeutic use | Lymphatic Metastasis | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | DNA-Binding Proteins - metabolism | Poly-ADP-Ribose Binding Proteins | Receptor, Epidermal Growth Factor - metabolism | Antineoplastic Agents - adverse effects | Breast Neoplasms - pathology | Antigens, Neoplasm - metabolism | Female | Breast Neoplasms - diagnosis | Neoplasm Staging
Journal Article
Details down arrow
16. Use of complementary and alternative medicine (CAM) in breast cancer patients. Efficacy and interactions
by Damkier, Anette and Paludan-Müller, Christine and Knoop, Ann Søegaard
Ugeskrift for læger, 09/2007, Volume 169, Issue 37, pp. 3111 - 3114
Humans | Risk Factors | Treatment Outcome | Antineoplastic Agents - therapeutic use | Complementary Therapies - adverse effects | Breast Neoplasms - drug therapy | Antineoplastic Agents - metabolism | Breast Neoplasms - therapy | Animals | Complementary Therapies - utilization | Breast Neoplasms - psychology | Herb-Drug Interactions | Denmark | Quality of Life | Female | Complementary Therapies - statistics & numerical data | Index Medicus
Journal Article
Details down arrow
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.